LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis.

"Declarations Ethics approval and consent to participateThe study was authorized by the Ethics Committee of Union Hospital of Huazhong University of Science and Technology. All participants provided written informed consent. Consent for publicationAll authors had read and agreed to publish the paper. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding This study was funded by the Key Program of Natural Science Foundation of Hubei Province (Grant No. 2021BCA142), the National Natural Science Foundation of China (Grant No. 82203813, 82203879, 82303861, and 82373055), the High-level Talents Program of Hainan Province Natural Science Foundation (823RC594), the Fundamental Research Funds for the Central Universities (2042023kf0012), Natural Science Foundation of Hubei Province (2022CFB883), China Postdoctoral Science Foundation (2021MD703960), General Hospital of Central Theater Command of Chinese People’s Liberation Army Foundation (ZZYCZ202107), General Hospital Of Central Theater Command and Hubei Key Laboratory of Central Nervous System Tumor and Intervention Foundation (ZZYKF202202)."